I now have a thorough picture from Miller's Anesthesia (the gold-standard reference for this topic). Let me compile the complete study guide.
Here is your complete study guide for Local Anaesthetic Agents - Unit 3, Pharmacology of Peripheral Nervous System, Semester 4.
Local Anaesthetic Agents - Complete Study Guide
Overview
Local anaesthetics (LAs) are drugs that produce reversible loss of sensation in a localised region by blocking nerve impulse conduction, without loss of consciousness. This is a high-yield topic that spans basic science through clinical application.
1. Chemistry and Classification
The LA Molecule
Every classical LA has three parts:
- Aromatic ring (lipophilic end, gives membrane affinity)
- Intermediate chain - either an ester (-COO-) or amide (-NHCO-) linkage
- Tertiary amine (hydrophilic end, partly protonated at physiologic pH)
Two Major Classes
| Feature | Aminoesters | Aminoamides |
|---|
| Bond | Ester | Amide |
| Examples | Procaine, Cocaine, Chloroprocaine, Tetracaine, Benzocaine | Lidocaine, Bupivacaine, Ropivacaine, Prilocaine, Mepivacaine, Levobupivacaine |
| Metabolism | Plasma pseudocholinesterase (rapid) | Hepatic microsomal enzymes (slower) |
| Allergy | More common (PABA derivative) | Rare |
| Stability | Less stable | More stable |
Physicochemical Properties to Know
- pKa: Determines onset speed. Lower pKa = more unionised drug at pH 7.4 = faster onset (e.g. lidocaine pKa 7.7, chloroprocaine pKa 8.7)
- Lipid solubility: Determines potency. More lipophilic = more potent (bupivacaine > lidocaine > procaine)
- Protein binding: Determines duration. Higher protein binding = longer duration (bupivacaine ~95% protein bound)
- pKa, lipid solubility, and protein binding are the three pillars of structure-activity relationships
2. Mechanism of Action
Physiology of Nerve Conduction (prerequisite)
- Resting membrane potential: -60 to -90 mV
- Na+/K+ ATPase maintains the gradient
- Action potential is driven by rapid Na+ influx through voltage-gated Na+ channels (VGNCs)
How LAs Work (step by step)
- LA deposited near the nerve diffuses through the nerve sheath
- Unionised (base) form crosses the axonal membrane
- Inside the axoplasm, at lower pH, the drug re-ionises to the cationic (charged) form
- The cationic form binds to the intracellular face of voltage-gated Na+ channels
- This blocks channel opening (prevents activation/depolarisation)
- No action potential = no nerve conduction = anaesthesia
Key Concepts
- Tonic (resting) block: Drug binds when channel is in resting state
- Phasic (use-dependent) block: Repeated stimulation allows more drug to enter open channels; block deepens with activity
- Ion trapping: In infected/inflamed tissue (acidic pH), more drug stays ionised outside the cell and cannot cross the membrane - this is why LAs work poorly in infected tissue
Na+ Channel Isoforms
- Nav1.7, Nav1.8, Nav1.9 are key neuronal isoforms - mutations lead to congenital pain insensitivity or erythromelalgia (clinically relevant)
3. Differential Nerve Block (Order of Block)
Nerve fibres are blocked in a predictable order. Know this:
| Order | Fibre type | Function lost |
|---|
| 1st | C fibres (small, unmyelinated) | Pain and temperature |
| 2nd | B fibres | Preganglionic autonomic |
| 3rd | A-delta fibres | Pain, cold, touch |
| 4th | A-gamma | Muscle spindle tone |
| 5th | A-beta | Touch, pressure, vibration |
| 6th | A-alpha (largest) | Motor, proprioception (last to go) |
Mnemonic: "Small before large" - pain disappears before motor power
4. Clinical Pharmacology
Factors Affecting LA Activity in Practice
| Factor | Effect |
|---|
| Concentration/dose | Higher dose = denser block |
| Site of injection | Epidural > peripheral (more vascular = faster absorption = shorter duration) |
| Addition of vasoconstrictor (epinephrine) | Reduces absorption, prolongs duration, decreases systemic toxicity |
| Carbonation/pH adjustment (NaHCO3) | Increases unionised fraction, speeds onset |
| Pregnancy | Enhanced sensitivity (progesterone lowers threshold) |
| Inflammation/infection | Reduces efficacy (acidic environment) |
Vasoconstrictors as Additives
- Epinephrine (most common): 1:200,000 concentration; prolongs block, reduces peak plasma concentration
- Clonidine/Dexmedetomidine: Alpha-2 agonists, prolong block
- Dexamethasone: Prolongs duration (mechanism: anti-inflammatory + direct neuronal effect)
- Buprenorphine: Opioid additive, prolongs analgesia
Specific Drugs to Know
| Drug | Class | Onset | Duration | Key Feature |
|---|
| Lidocaine (Lignocaine) | Amide | Fast | Medium (1-2h) | Most versatile, antiarrhythmic |
| Bupivacaine | Amide | Slow | Long (4-8h) | High cardiotoxicity risk |
| Ropivacaine | Amide | Moderate | Long | Less cardiotoxic than bupivacaine, more motor-sparing |
| Levobupivacaine | Amide | Moderate | Long | S-enantiomer of bupivacaine, safer than racemic |
| Procaine | Ester | Slow | Short | Prototype ester |
| Cocaine | Ester | Fast | Medium | Only LA with vasoconstrictor effect; ENT use only |
| Tetracaine (Amethocaine) | Ester | Slow | Long | Spinal & topical use |
| Prilocaine | Amide | Fast | Medium | Methemoglobinemia risk |
| Benzocaine | Ester | Fast | Short | Topical only (insoluble in water); methemoglobinemia |
5. Routes and Types of Regional Anaesthesia
- Infiltration anaesthesia: Subcutaneous injection at the surgical site
- Topical/surface anaesthesia: EMLA cream (lidocaine + prilocaine), throat spray
- Nerve block: Single nerve (ulnar, radial) or major plexus (brachial plexus)
- IV Regional Anaesthesia (Bier's block): IV LA into exsanguinated, tourniquet-isolated limb; lidocaine used
- Spinal (intrathecal) anaesthesia: Injected into CSF (subarachnoid space); bupivacaine/tetracaine
- Epidural anaesthesia: Injected into epidural space; bupivacaine/ropivacaine
- Tumescent anaesthesia: Large volumes of dilute LA + epinephrine + NaHCO3 (used in liposuction)
6. Pharmacokinetics
- Absorption: Depends on site, vascularity, drug properties, and use of vasoconstrictors. Order: IV > tracheal > intercostal > caudal > epidural > brachial plexus > subcutaneous
- Distribution: Highly bound to alpha-1-acid glycoprotein (AAG) and albumin in plasma
- Metabolism:
- Esters: Rapid hydrolysis by plasma pseudocholinesterase (to PABA in some)
- Amides: Hepatic cytochrome P450 (slower; accumulate in liver disease)
- Excretion: Renal (metabolites)
7. Toxicity (High-Yield!)
Systemic Toxicity (LAST - Local Anaesthetic Systemic Toxicity)
CNS Toxicity (occurs at lower blood levels than CVS):
- Early: perioral tingling, metallic taste, tinnitus, lightheadedness, visual/auditory disturbance
- Progressive: disorientation, drowsiness, muscular twitching
- Severe: tonic-clonic seizures
- Very severe: CNS depression, respiratory arrest
Cardiovascular Toxicity (requires higher blood levels):
- Myocardial depression, bradycardia, conduction block
- Hypotension, ventricular arrhythmias, cardiac arrest
- Bupivacaine is the most cardiotoxic - causes "3 Cs": reentrant arrhythmias, cardiac depression, cardiovascular collapse
- Bupivacaine cardiotoxicity difficult to treat; may require Intralipid (lipid emulsion rescue)
Treatment of LAST:
- Stop injection, call for help
- Airway/O2/ventilation (prevent acidosis - worsens toxicity)
- Benzodiazepine or propofol for seizures
- 20% Intralipid emulsion IV (lipid sink - sequesters LA from cardiac tissue)
- CPR if needed; avoid vasopressin and Ca2+ channel blockers
Specific Adverse Effects
| Drug | Specific toxicity |
|---|
| Prilocaine | Methemoglobinemia (metabolite o-toluidine oxidises Hb); treat with methylene blue |
| Benzocaine | Methemoglobinemia |
| Aminoesters (procaine) | Allergic reactions (IgE-mediated; PABA metabolite) |
| Cocaine | Cardiovascular stimulation, addiction, vasoconstriction |
| Bupivacaine | Severe, refractory cardiotoxicity |
Local Tissue Toxicity
- All LAs are neurotoxic at high concentrations in direct contact with nerve (transient neurological symptoms with spinal lidocaine)
- Myotoxicity possible with direct muscle injection
8. Special Topics
Chiral LAs
- Bupivacaine is a racemic mixture (R+S enantiomers)
- Ropivacaine and levobupivacaine are pure S(-) enantiomers
- S-enantiomers have lower cardiac toxicity than the R(+) form
- This is the basis for preferring ropivacaine/levobupivacaine over bupivacaine when prolonged block is needed
Why LAs Fail in Infection
- Infected tissue is acidic (low pH)
- At low pH, more drug remains in ionised (cationic) form
- Ionised form cannot cross the lipid membrane to reach the binding site
- Result: poor block
Cocaine - Unique Properties
- The only LA that causes vasoconstriction (blocks norepinephrine reuptake)
- Used in ENT (nasal surgeries) as both LA + vasoconstrictor
- Has abuse potential; not used for injection anaesthesia
9. Key High-Yield One-Liners to Memorise
- LAs block Na+ channels from the inside (intracellular face) in the ionised form
- They cross membranes in the unionised (base) form
- Lower pKa = faster onset
- Higher lipid solubility = greater potency
- Higher protein binding = longer duration
- Esters metabolised by plasma cholinesterase; amides by liver
- Prilocaine causes methemoglobinemia
- Bupivacaine has the highest cardiotoxicity
- Treat LAST with 20% intralipid
- Epinephrine prolongs block by local vasoconstriction (reduces vascular absorption)
- LAs fail in infection because of ion trapping
- Differential block order: pain first, motor last
10. Likely Exam Questions (Semester 4 Level)
- Classify local anaesthetics with examples
- Mechanism of action of local anaesthetics
- Differences between ester and amide local anaesthetics
- Factors determining onset, potency, and duration
- Why does adrenaline prolong local anaesthesia?
- Why do LAs fail in infected tissue?
- Systemic toxicity of local anaesthetics - signs and management
- Methemoglobinemia - which drugs cause it and how is it treated?
- Bupivacaine vs. lidocaine - comparison
- Cocaine - unique pharmacological properties
- Order of nerve fibre susceptibility to LAs
Sources: Miller's Anesthesia 10th Edition (Ch. 25); Morgan & Mikhail's Clinical Anesthesiology 7e